Detalles de la búsqueda
1.
TRPM4 expression is associated with activated B cell subtype and poor survival in diffuse large B cell lymphoma.
Histopathology;
71(1): 98-111, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28248435
2.
Multiplex polymerase chain reaction-based prognostic models in diffuse large B-cell lymphoma patients treated with R-CHOP.
Br J Haematol;
174(6): 876-86, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27196819
3.
Low HIP1R mRNA and protein expression are associated with worse survival in diffuse large B-cell lymphoma patients treated with R-CHOP.
Exp Mol Pathol;
99(3): 537-45, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26341140
4.
Oncogenic Roles and Inhibitors of DNMT1, DNMT3A, and DNMT3B in Acute Myeloid Leukaemia.
Biomark Insights;
14: 1177271919846454, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31105426
5.
DNMT1 is predictive of survival and associated with Ki-67 expression in R-CHOP-treated diffuse large B-cell lymphomas.
Pathology;
49(7): 731-739, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-29074044
6.
FOXP2-positive diffuse large B-cell lymphomas exhibit a poor response to R-CHOP therapy and distinct biological signatures.
Oncotarget;
7(33): 52940-52956, 2016 Aug 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-27224915
Resultados
1 -
6
de 6
1
Próxima >
>>